Home / Health / GCRI Sees More Early Cancer Diagnoses: New Tech Aids Treatment
GCRI Sees More Early Cancer Diagnoses: New Tech Aids Treatment
4 Feb
Summary
- Mouth and breast cancers were 20% of GCRI admissions in late 2025.
- GCRI saw 1,931 men for mouth and 1,456 women for breast cancer.
- New technologies and awareness lead to earlier diagnoses and better outcomes.
From January to November 2025, mouth and breast cancers accounted for one in every five admissions at the Gujarat Cancer Research Institute (GCRI). The institute admitted 16,794 patients, with 1,931 men diagnosed with mouth cancer and 1,456 women with breast cancer. This period saw significant advancements in patient care and awareness.
GCRI director Dr. Shashank Pandya highlighted a shift in patient approach, noting more individuals seeking help at earlier stages. This rise in awareness, coupled with new diagnostic and treatment technologies, has improved oncologists' ability to achieve better recovery outcomes and preserve tissues. The institute also reported conducting 50 robotic surgeries in the past six months and introduced hyperthermic intraperitoneal chemotherapy (HIPAC) for abdominal cancers.
In alignment with World Cancer Day's theme 'United by Unique,' city oncologists emphasized personalized support and equitable treatment access. Events were held to mark the day, focusing on early diagnosis and intervention. Uday Vora, a cancer survivor, stressed the importance of community participation in dispelling myths and creating awareness, noting that early detection and intervention are crucial.
Dr. Jignesh Shah of the Ahmedabad Medical Association added that promoting awareness of preventive steps and self-screening empowers families. These collective efforts aim to combat the stigma associated with cancer and ensure timely and effective treatment for all.
